CHOLESTYRAMINE
NDC 70771-1070, CHOLESTYRAMINE, powder, for suspension, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1070
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202902
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/5.5g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1070-1 | 70771107001 | 231 g in 1 CONTAINER (70771-1070-1) |
| 70771-1070-2 | 70771107002 | 60 POUCH in 1 CARTON (70771-1070-2) / 5.5 g in 1 POUCH |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d7c6bc5e-1916-43bf-b943-98f00f41b8de
Use it
Look up 70771-1070 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1070 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1070. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.